Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
International Flavors & Fragrances
IFF
|
+$159M |
| 2 |
Broadcom
AVGO
|
+$140M |
| 3 |
Builders FirstSource
BLDR
|
+$128M |
| 4 |
Equinix
EQIX
|
+$98.7M |
| 5 |
ConocoPhillips
COP
|
+$89.1M |
Top Sells
| 1 |
GameStop
GME
|
+$746M |
| 2 |
Chevron
CVX
|
+$276M |
| 3 |
Apple
AAPL
|
+$238M |
| 4 |
BMCH
BMC Stock Holdings, Inc
BMCH
|
+$197M |
| 5 |
CHL
China Mobile Limited
CHL
|
+$178M |
Sector Composition
| 1 | Financials | 17.74% |
| 2 | Technology | 15.68% |
| 3 | Industrials | 13.56% |
| 4 | Consumer Discretionary | 12.2% |
| 5 | Healthcare | 10.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Amneal Pharmaceuticals
AMRX
$3.08B
| $6.18M | ﹤0.01% |
917,707
+469,059
| +105% | +$3.16M |
|
2502
Potbelly
PBPB
$514M
| $6.17M | ﹤0.01% |
1,043,493
-165,927
| -14% | -$981K |
|
2503
Transmedics
TMDX
$3.67B
| $6.13M | ﹤0.01% |
147,669
+125,823
| +576% | +$5.22M |
|
|
YELL
2504
DELISTED
Yellow Corporation Common Stock
YELL
| $6.08M | ﹤0.01% |
691,473
-59,950
| -8% | -$527K |
|
|
VNTR
2505
DELISTED
Venator Materials PLC
VNTR
| $6.08M | ﹤0.01% |
1,312,043
+137,236
| +12% | +$635K |
|
|
RNWK
2506
DELISTED
RealNetworks Inc
RNWK
| $6.05M | ﹤0.01% |
1,415,661
+44,958
| +3% | +$192K |
|
2507
Iovance Biotherapeutics
IOVA
$861M
| $6.04M | ﹤0.01% |
191,150
+52,425
| +38% | +$1.66M |
|
2508
Orrstown Financial Services
ORRF
$681M
| $6.04M | ﹤0.01% |
270,629
+17,706
| +7% | +$395K |
|
|
CBAY
2509
DELISTED
Cymabay Therapeutics
CBAY
| $6M | ﹤0.01% |
1,322,192
+70,206
| +6% | +$319K |
|
2510
Impinj
PI
$5.53B
| $5.99M | ﹤0.01% |
105,479
-153
| -0.1% | -$8.69K |
|
|
WSR
2511
Whitestone REIT
WSR
$656M
| $5.99M | ﹤0.01% |
617,251
-20,515
| -3% | -$199K |
|
2512
Nordic American Tanker
NAT
$675M
| $5.97M | ﹤0.01% |
1,837,229
-174,867
| -9% | -$568K |
|
2513
Aware
AWRE
$58.2M
| $5.97M | ﹤0.01% |
1,634,383
-27,023
| -2% | -$98.6K |
|
2514
10x Genomics
TXG
$1.57B
| $5.96M | ﹤0.01% |
32,946
+19,324
| +142% | +$3.49M |
|
2515
Fastly
FSLY
$1.08B
| $5.95M | ﹤0.01% |
88,529
+9,310
| +12% | +$626K |
|
|
BPMC
2516
DELISTED
Blueprint Medicines
BPMC
| $5.95M | ﹤0.01% |
61,117
-5,745
| -9% | -$559K |
|
|
GBL
2517
DELISTED
GAMCO Investors, Inc.
GBL
| $5.93M | ﹤0.01% |
319,867
-26,119
| -8% | -$484K |
|
|
WBK
2518
DELISTED
Westpac Banking Corporation
WBK
| $5.93M | ﹤0.01% |
319,222
-8,845
| -3% | -$164K |
|
2519
Stantec
STN
$12.4B
| $5.9M | ﹤0.01% |
137,854
| – | – |
|
2520
KalVista Pharmaceuticals
KALV
$775M
| $5.87M | ﹤0.01% |
228,625
+22,108
| +11% | +$568K |
|
|
CVLY
2521
DELISTED
Codorus Valley Bancorp Inc
CVLY
| $5.87M | ﹤0.01% |
318,960
+14,429
| +5% | +$266K |
|
2522
TransAlta
TAC
$3.76B
| $5.86M | ﹤0.01% |
619,200
-31,016
| -5% | -$293K |
|
2523
First Bank
FRBA
$415M
| $5.85M | ﹤0.01% |
479,873
+29,104
| +6% | +$355K |
|
|
ERF
2524
DELISTED
Enerplus Corporation
ERF
| $5.83M | ﹤0.01% |
1,163,254
-28,606
| -2% | -$143K |
|
|
KIN
2525
DELISTED
Kindred Biosciences, Inc.
KIN
| $5.83M | ﹤0.01% |
1,174,979
-13,906
| -1% | -$69K |
|